bioRxivPharmacology & ToxicologyPreprint
Exploring Relationships Between In Vitro Aqueous Solubility and Permeability and In Vivo Fraction Absorbed
Abstract
IntroductionSolubility/dissolution and permeability are essential determinants of gastrointestinal absorption of drugs. In vitro aqueous solubility (S) and apparent permeability (Papp) are commonly used as measurements and predictors of in vivo fraction absorbed (fa) and BCS-classing in humans. The objective of this study was to explore the relationships between in vitro aqueous S and Dose number (Do) and in vivo fa and in vitro Papp and in vivo fa and the predictive power of in vitro aqueous S, Do and Papp. MethodsIn vitro and in vivo data were taken from studies in the literature and correlated. In vitro S data were produced in various laboratories and with different methodologies. In vitro Papp data were produced using Caco-2 and MDCK cells in various laboratories and Caco-2 and RRCK cells in one laboratory each. Do was estimated as oral dose / (S * 250 mL). Results452 S data and 1480 Papp data were found and used. There was no correlation (R2=0.0) between in vitro log S and Do vs in vivo fa, not even at S<1 mg/L or not for compounds with <90 % and <30 % in vivo fa. A R2 of 0.43 was found between log Caco-2 Papp and in vivo fa. The corresponding R2 for Caco-2 from one laboratory was 0.65. The interlaboratory R2 for the Caco-2 model was 0.48. R2-estimates for Caco-2 vs MDCK and Caco-2 vs RRCK Papp were 0.23 and 0.21, respectively. Discussion and ConclusionAqueous S appears to have no predictive value of in vivo fa in humans, not even at low S or after correction for dose. The shows that one should not base human biopharmaceutical predictions based on aqueous S. Log Caco-2 Papp explains about half of the variance of in vivo fa in humans. The poor correlations found between Caco-2 and the two other Papp-models (MDCK and RRCK) demonstrate considerable methodological differences. The unexplained variance does not appear to be explained by S and dose, but rather by in vitro-in vivo difference in permeability and poor/absent relationship between in vitro S and in vivo dissolution potential.
- organism: human
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vitro to in vivo pharmacokinetic translation guidance
U. Fagerholm·bioRxiv·Sep 26, 2022
- Human ADME/PK is lost in translation and prediction from in silico to in vitro to in vivo
Urban Fagerholm, Sven Hellberg·bioRxiv·Feb 17, 2025
- An analysis of laboratory variability and thresholds for human in vitro ADME/PK methods
U. Fagerholm·bioRxiv·Sep 27, 2022
- Prediction of Biopharmaceutical Characteristics of PROTACs using the ANDROMEDA by Prosilico Software
U. Fagerholm, S. Hellberg, … O. Spjuth·bioRxiv·Sep 22, 2022
- ANDROMEDA by Prosilico Software Successfully Predicts Human Clinical Pharmacokinetics of 300 Drugs Out of Reach for In Vitro Methods
U. Fagerholm, S. Hellberg, … O. Spjuth·bioRxiv·Oct 5, 2022
- Comparison of Software for Prediction of Fraction Absorbed and Unbound in Humans
Urban Fagerholm·bioRxiv·Sep 7, 2025